IL18 and acute kidney injury: In addition, there were other novel renal injury biomarkers, such as kidney injury molecular-1 (KIM-1) and interleukin-18 (IL-18), which reflecting renal tubular damage and inflammation of AKI, also shown to predict the progression of AKI in the setting of ICU and cardiac surgery, and presented modest performance [10, 11].